New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 27, 2014
10:07 EDTAEGR, SLF, SRC, QTNT, SABR, PFE, FRSH, OILT, MFC, GPT, BKW, ARES, AWH, TRXCOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Aegerion (AEGR) initiated with a Sell at Goldman... Allied World (AWH) initiated with a Buy at CRT Capital... Ares Management (ARES) initiated with a Buy at BofA/Merrill... Burger King (BKW) initiated with an Equal Weight at Morgan Stanley... Gramercy Property Trust (GPT) initiated with a Buy at BofA/Merrill... Manulife Financial (MFC) initiated with a Buy at Canaccord... Oiltanking Partners (OILT) initiated with a Market Perform at Wells Fargo... Papa Murphy's (FRSH) initiated with a Buy at Jefferies... Pfizer (PFE) reinstated with a Buy at Goldman... Quotient (QTNT) initiated with a Buy at UBS... Sabre (SABR) initiated with a Buy at BofA/Merrill... Spirit Realty (SRC) initiated with a Neutral at BofA/Merrill... Sun Life Financial (SLF) initiated with a Buy at Canaccord... TransEnterix (TRXC) initiated with an Outperform at RBC Capital.
News For AEGR;AWH;ARES;BKW;GPT;MFC;OILT;FRSH;PFE;SABR;QTNT;SRC;SLF;TRXC From The Last 14 Days
Check below for free stories on AEGR;AWH;ARES;BKW;GPT;MFC;OILT;FRSH;PFE;SABR;QTNT;SRC;SLF;TRXC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
16:18 EDTPFEPuma Biotech now responsible for R&D expenses associated with legacy trials
Subscribe for More Information
06:43 EDTBKWChina food scandal expands, ropes-in Starbucks, others, Reuters says
Subscribe for More Information
July 21, 2014
07:01 EDTOILTOiltanking Partners board raises quarterly distribution to 26c
Subscribe for More Information
July 17, 2014
16:26 EDTARESAres Management to acquire National Veterinary Associates
Subscribe for More Information
09:05 EDTBKWCarrols Restaurant purchases 21 Burger King restaurants
Subscribe for More Information
08:08 EDTPFEBristol-Myers, Pfizer announce enrollment in Phase IV EMANATE trial for Eliquis
Subscribe for More Information
July 16, 2014
10:36 EDTPFETreasury calls on Congress to halt inversion deals
Subscribe for More Information
10:00 EDTSRCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:27 EDTPFEPfizer to acquire InnoPharma for upfront cash payment of $225M
Subscribe for More Information
08:14 EDTSRCSpirit Realty upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
07:59 EDTPFETreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
07:04 EDTPFEPfizer says primary endpoint met in Phase 3 study of BeneFIX
Pfizer announced the positive results of a Phase 3 study comparing a prophylaxis regimen of BeneFIX Coagulation Factor IX 100 IU/kg once-weekly to on-demand treatment in people with moderately severe to severe hemophilia B. The top-line results of the study showed that the primary study endpoint was met and hemophilia B patients taking once-weekly BeneFIX showed a statistically significant reduction in the annualized bleeding rate relative to on-demand treatment with BeneFIX. In the study, the median ABR value, a commonly used measure of efficacy for prophylaxis regimens in hemophilia, was 2.0 for the prophylaxis regimen, compared to 33.6 for the on-demand regimen, representing a 94% decrease in bleeding rates. The mean ABR value was 3.6 for the prophylaxis period, compared to 32.9 for the on-demand treatment, which represents a reduction of 89%. Study results also showed that prophylaxis treatment significantly reduced both spontaneous and traumatic ABR compared to on-demand treatment with BeneFIX. In addition to meeting the primary endpoint, the secondary study endpoints showed that none of the 1,254 prophylaxis infusions administered during the study were associated with a less than expected therapeutic effect occurrence, which was defined as a spontaneous bleed occurring within 48 hours of a prophylaxis infusion. These results are preliminary, top-line data and are subject to additional analyses. Complete results from this study will be submitted for presentation at upcoming medical congresses and submitted for publication in a peer-reviewed journal.
July 15, 2014
10:56 EDTAEGRFed calls small cap social media, biotech valuations 'stretched'
The Board of Governors of the Federal Reserve in its Monetary Policy Report dated today said valuation metrics in "some sectors" appear substantially stretched, "particularly those for smaller firms in the social media and biotechnology industries, despite a notable downturn in equity prices for such firms early in the year." A later part in the document reads, "Equity valuations of smaller firms as well as social media and biotechnology firms appear to be stretched, with ratios of prices to forward earnings remaining high relative to historical norms." The specific targeting of sectors by the Fed seems to be having an impact on stocks in the social media and biotech spaces. Shares of Yelp (YELP) are down over 5% to $67.51, while Twitter (TWTR) and Facebook (FB) are each down 2%. Celgene (CELG) and Amgen (AMGN) are leading the biotech space lower with pullbacks of greater than 1%.
July 11, 2014
11:31 EDTAEGROptions with increasing implied volatility
Options with increasing implied volatility: INO AEGR UBNT INVN WTW OREX GNC CREE SD SAN
09:29 EDTGPTGramercy Property Trust announces pricing for Industrial Property OP Unit
Subscribe for More Information
July 10, 2014
15:25 EDTGPTGramercy Property Trust files to sell 3.8M shares of common for holders
09:30 EDTSABRSabre signs comprehensive technology agreement with HNA Hotels & Resorts
Subscribe for More Information
06:06 EDTAEGRWestfield Capital Management reports 10.88% passive stake in Aegerion
Subscribe for More Information
July 9, 2014
09:32 EDTSABRSabre renews technology agreement with Hilton
Subscribe for More Information
06:49 EDTPFEPfizer given dismissal of U.S. investor class action before trial, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use